Search Results - "Lofberg, R"

Citrullination is an inflammation-dependent process by Makrygiannakis, D, af Klint, E, Lundberg, I E, Löfberg, R, Ulfgren, A-K, Klareskog, L, Catrina, A I

“…Objectives: To study the presence of citrullinated proteins in inflammatory conditions and in clinically non-affected tissues of controls. Methods: Synovial…”
Get full text

Long‐term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients by Angelison, L., Almer, S., Eriksson, A., Karling, P., Fagerberg, U., Halfvarson, J., Thörn, M., Björk, J., Hindorf, U., Löfberg, R., Bajor, A., Hjortswang, H., Hammarlund, P., Grip, O., Torp, J., Marsal, J., Hertervig, E.

“…Summary Background Real‐life long‐term data on infliximab treatment in ulcerative colitis are limited. Aim To study the long‐term efficacy and safety of…”
Get full text

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis by Geboes, K, Riddell, R, Öst, A, Jensfelt, B, Persson, T, Löfberg, R

“…BACKGROUND Evaluation of histological activity in ulcerative colitis needs to be reproducible but has rarely been tested. This could be useful both clinically…”
Get full text

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County by Ljung, T, Karlén, P, Schmidt, D, Hellström, P M, Lapidus, A, Janczewska, I, Sjöqvist, U, Löfberg, R

“…Background: Several placebo controlled studies have demonstrated the efficacy of infliximab in inflammatory bowel disease (IBD) but the potential toxicity of…”
Get full text

Risk of haematopoietic cancer in patients with inflammatory bowel disease by Askling, J, Brandt, L, Lapidus, A, Karlén, P, Björkholm, M, Löfberg, R, Ekbom, A

“…Background and aims: Several chronic inflammatory conditions are associated with an increased risk of lymphoma. Whether this applies to inflammatory bowel…”
Get full text

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE by Löfberg, Robert, Louis, Edouard V., Reinisch, Walter, Robinson, Anne M., Kron, Martina, Camez, Anne, Pollack, Paul F.

“…Background: Data regarding the effectiveness of anti‐tumor necrosis factor (TNF) agents for resolution of extraintestinal manifestations (EIMs) are scarce. The…”
Get full text

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease by Sandborn, William J., Feagan, Brian G., Hanauer, Stephen B., Lochs, Herbert, Lofberg, Robert, Modigliani, Robert, Present, Daniel H., Rutgeerts, Paul, Scholmerich, Jurgen, Stange, Eduard F., Sutherland, Lloyd R.

Get full text

mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review by Hanai, H, Takeda, Y, Eberhardson, M, Gruber, R, Saniabadi, A.R, Winqvist, O, Lofberg, R

“…Patients with active inflammatory bowel disease (IBD) have elevated and activated myeloid leucocytes which infiltrate the colonic mucosa in vast numbers…”
Get full text

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study by Oxelmark, Lena, Lindberg, Annelie, Löfberg, Robert, Sternby, Berit, Eriksson, Anders, Almer, Sven, Befrits, Ragnar, Fossum, Bjöörn, Karlén, Per, Broström, Olle, Tysk, Curt

“…BACKGROUNDThere is an increasing interest in complementary and alternative medicine (CAM) in patients with chronic diseases, including those with inflammatory…”
Get full text

Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study by Karlén, P, Kornfeld, D, Broström, O, Löfberg, R, Persson, P-G, Ekbom, A

“…Background—Colonoscopic surveillance is a standard procedure in many patients with long standing, extensive ulcerative colitis (UC), in order to avoid death…”
Get full text

Family history as a risk factor for colorectal cancer in inflammatory bowel disease by Askling, Johan, Dickman, Paul W., Karlén, Per, Broström, Olle, Lapidus, Annika, Löfberg, Robert, Ekbom, Anders

“…Background & Aims: Familial colorectal cancer (CRC) is a risk factor for CRC in healthy individuals and, as indicated by case-control studies, possibly in…”
Get full text

Review article: medical treatment of mild to moderately active Crohn's disease by Lofberg, R

“…Crohn's disease is a chronic, debilitating subset of inflammatory bowel diseases, which may affect any part of the gastrointestinal tract. The most common…”
Get full text

Clinical trial: the safety and short‐term efficacy of recombinant cholera toxin B subunit in the treatment of active Crohn’s disease by STÅL, P., BEFRITS, R., RÖNNBLOM, A., DANIELSSON, Å., SUHR, O., STÅHLBERG, D., BRINKBERG LAPIDUS, A., LÖFBERG, R.

“…Aliment Pharmacol Ther 31, 387–395 Summary Background  The cholera toxin B subunit ameliorates experimentally induced colitis in mice. In humans, cholera toxin…”
Get full text

Clinical course of colorectal Crohn's disease: A 35-year follow-up study of 507 patients by Lapidus, Annika, Bernell, Olle, Hellers, Göran, Löfberg, Robert

“…Background & Aims: Crohn's disease (CD) confined to the colon and rectum is an increasing clinical entity. The aim of this study was to assess the features and…”
Get full text

Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission : A predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials by SANDBORN, William J, LÖFBERG, Robert, FEAGAN, Brian G, HANAUER, Stephen B, CAMPIERI, Massimo, GREENBERG, Gordon R

“…To evaluate the efficacy and safety of oral budesonide for maintenance of remission in patients with mild to moderately active Crohn's disease (CD) of the…”
Get full text

Oral budesonide for prevention of postsurgical recurrence in Crohn's disease by Hellers, Göran, Cortot, Antoine, Jewell, Derek, Leijonmarck, Carl Eric, Löfberg, Robert, Malchow, Helmut, Nilsson, Lars-Göran, Pallone, Franco, Pena, Salvador, Persson, Tore, Prantera, Cosimo, Rutgeerts, Paul

“…Background & Aims: Prevention of postoperative recurrence after resection for Crohn's disease (CD) would be of great clinical benefit. The efficacy of oral…”
Get full text

Down-regulation of interferon-γ parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease : a 12-month follow-up study by MURATOV, V, LUNDAHL, J, ULFGREN, A. K, ELVIN, K, FEHRMAN, I, AHLBORG, N, OST, A, HITTEL, N, SANIABADI, A, LÖFBERG, R

“…Pilot studies have indicated a therapeutic role for an apheresis device (Adacolumn) that selectively adsorbs leukocytes in patients with inflammatory bowel…”
Get full text

Kinetics of the soluble IL-1 receptor type I during treatment with an LCAP filter in patients with inflammatory bowel disease by Muratov, V., Paulsson, J.M., Elvin, K., Löfberg, R., Lundahl, J.

“…Leukocyte apheresis primarily used for treatment of inflammatory diseases such as inflammatory bowel disease (IBD). Beside an effect of the apheresis column,…”
Get full text

Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis by Gullberg, K, Stahlberg, D, Liljeqvist, L, Tribukait, B, Reinholt, FP, Veress, B, Lofberg, R

“…BACKGROUND & AIMS: Some patients with ulcerative colitis (UC) receiving an ileal pelvic pouch with ileoanal anastomosis (IPAA) develop persistent severe…”
Get full text

Incidence of Crohn’s disease in Stockholm County 1955–1989 by Lapidus, A, Bernell, O, Hellers, G, Persson, P-G, Löfberg, R

“…Aim—To evaluate the incidence of Crohn’s disease in Stockholm County between 1955 and 1989. Methods—A cohort of 1936 patients with Crohn’s disease was…”
Get full text